大家健康(中旬版)
大傢健康(中旬版)
대가건강(중순판)
GOOD HEALTH FOR ALL
2014年
11期
13-14
,共2页
甲巯咪唑%普萘洛尔%甲亢%疗效观察
甲巰咪唑%普萘洛爾%甲亢%療效觀察
갑구미서%보내락이%갑항%료효관찰
Methimazole%propranolol%Hyperthyroidism%curative effect observation
目的:探究甲巯咪唑联合普萘洛尔治疗甲状腺功能亢进患者的临床疗效。方法:回顾性分析本院2009年12月至2013年12月收治的132例甲状腺功能亢进患者临床资料,所有患者随机分成两组,联合用药组采用甲巯咪唑联合普萘洛尔进行治疗,对照组仅采用甲巯咪唑进行治疗,比较两组的治疗效果。结果:治疗3个月后,联合用药组患者的疗效、总甲状腺素、游离甲状腺素、总三碘甲状腺原氨酸、游离三碘甲状腺原氨酸和高敏促甲状腺素水平与对照组患者相比改善效果更加显著,差异具有统计学意义(P <0.05)。结论:临床上采用甲巯咪唑联合普萘洛尔治疗甲状腺功能亢进的疗效更加确切,安全性能高,值得临床推广使用。
目的:探究甲巰咪唑聯閤普萘洛爾治療甲狀腺功能亢進患者的臨床療效。方法:迴顧性分析本院2009年12月至2013年12月收治的132例甲狀腺功能亢進患者臨床資料,所有患者隨機分成兩組,聯閤用藥組採用甲巰咪唑聯閤普萘洛爾進行治療,對照組僅採用甲巰咪唑進行治療,比較兩組的治療效果。結果:治療3箇月後,聯閤用藥組患者的療效、總甲狀腺素、遊離甲狀腺素、總三碘甲狀腺原氨痠、遊離三碘甲狀腺原氨痠和高敏促甲狀腺素水平與對照組患者相比改善效果更加顯著,差異具有統計學意義(P <0.05)。結論:臨床上採用甲巰咪唑聯閤普萘洛爾治療甲狀腺功能亢進的療效更加確切,安全性能高,值得臨床推廣使用。
목적:탐구갑구미서연합보내락이치료갑상선공능항진환자적림상료효。방법:회고성분석본원2009년12월지2013년12월수치적132례갑상선공능항진환자림상자료,소유환자수궤분성량조,연합용약조채용갑구미서연합보내락이진행치료,대조조부채용갑구미서진행치료,비교량조적치료효과。결과:치료3개월후,연합용약조환자적료효、총갑상선소、유리갑상선소、총삼전갑상선원안산、유리삼전갑상선원안산화고민촉갑상선소수평여대조조환자상비개선효과경가현저,차이구유통계학의의(P <0.05)。결론:림상상채용갑구미서연합보내락이치료갑상선공능항진적료효경가학절,안전성능고,치득림상추엄사용。
Objective:To analysis the clinical effect of methimazole combined with propranolol in the treatment of hyperthyroidism.Methods:The clinical data of 132 patients with hyperthyroidism admitted into our hospital from December 2009 to December 2013 were analyzed.Methimazole combining with proprano-lol was provided to the combined group (n =66),while only methimazole was given to the control group (n =66),the clinical efficacy and thyroid level were compared between two groups.Results:The clinical effect and the levels of total thyroxin,free thyroxin,total triiodothyronine,free triiodothyronine,and thyroid-stimulating hormone in high sensitivity in the combined group were all remarkably superior to those in the control group (P <0.05).Conclusion:In the treat-ment of hyperthyroidism,the combination of methimazole and propranolol can obtain a definite effect,which is safe and is worthy of expansion in clinic.